+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 48 Pages
  • December 2022
  • GlobalData
  • Advaxis Inc
  • ID: 1292019
Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development, and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology, an antigen delivery platform that activates the immune system naturally. The Lm technology uses bioengineered live attenuated Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T cells directed against a cancer antigen. Its immunotherapy candidates are intended for the treatment of neoantigen-directed therapies, prostate cancer, and human papilloma virus-associated cancers. The company has partnerships with various biopharmaceutical companies to develop and commercialize proprietary cancer immunotherapies. Advaxis is headquartered in Princeton, New Jersey, the US.

Advaxis Inc Key Recent Developments

  • Oct 20, 2022: Advaxis enters merger deal with biotech firm Ayala
  • Sep 12, 2022: Advaxis Reports Third Quarter Ended July 31 2022 Financial Results and Provides a Business Update
  • Jun 08, 2022: Advaxis Reports Second Quarter Ended April 30, 2022 Financial Results and Provides a Business Update
  • Mar 17, 2022: Advaxis Reports First Quarter Ended January 31, 2022 Financial Results and Provides a Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Advaxis Inc - Key Facts
  • Advaxis Inc - Key Employees
  • Advaxis Inc - Key Employee Biographies
  • Advaxis Inc - Major Products and Services
  • Advaxis Inc - History
  • Advaxis Inc - Company Statement
  • Advaxis Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Advaxis Inc - Business Description
  • R&D Overview
  • Advaxis Inc - Corporate Strategy
  • Advaxis Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Advaxis Inc - Strengths
  • Advaxis Inc - Weaknesses
  • Advaxis Inc - Opportunities
  • Advaxis Inc - Threats
  • Advaxis Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Advaxis Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Oct 20, 2022: Advaxis enters merger deal with biotech firm Ayala
  • Sep 12, 2022: Advaxis Reports Third Quarter Ended July 31 2022 Financial Results and Provides a Business Update
  • Jun 08, 2022: Advaxis Reports Second Quarter Ended April 30, 2022 Financial Results and Provides a Business Update
  • Mar 17, 2022: Advaxis Reports First Quarter Ended January 31, 2022 Financial Results and Provides a Business Update
  • Feb 14, 2022: Advaxis Reports Fiscal Year 2021 Financial Results and Provides a Business Update
  • Sep 10, 2021: Advaxis Reports 3rd Quarter Ended July 31, 2021 Financial Results and Provides a Business Update
  • Jun 14, 2021: Advaxis Reports Second Quarter Ended April 30, 2021 Financial Results and Provides a Business Update
  • Apr 12, 2021: Advaxis announces $20 million registered direct offering priced at-the-market under Nasdaq Rules
  • Mar 23, 2021: Advaxis to Present Corporate Overview at the Benzinga Biotech Small Cap Conference
  • Mar 16, 2021: Advaxis reports first quarter ended january 31, 2021 financial results and provides a business update
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Advaxis Inc, Key Facts
  • Advaxis Inc, Key Employees
  • Advaxis Inc, Key Employee Biographies
  • Advaxis Inc, Major Products and Services
  • Advaxis Inc, History
  • Advaxis Inc, Key Competitors
  • Advaxis Inc, Ratios based on current share price
  • Advaxis Inc, Annual Ratios
  • Advaxis Inc, Interim Ratios
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Advaxis Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Advaxis Inc, Performance Chart (2017 - 2021)
  • Advaxis Inc, Ratio Charts
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Advaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Oxurion NV
  • Celldex Therapeutics Inc
  • bluebird bio Inc
  • Amicus Therapeutics Inc
  • Agenus Inc